Surveillance of HIV drug resistance in children newly diagnosed with HIV by early infant diagnosis

Overview

 This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period.

Data on HIVDR and the prevalence of PMTCT exposure in this target population can provide critical information to support optimal choice of first- and second-line ART regimens.